Aptose Biosciences Inc.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • GeneSense Technologies
  • Lorus Therapeutics Inc.
  • Aptose Biosciences U.S
  • Aptose Suisse
  • NuChem Pharmaceuticals
See more in Biomedtracker

Latest on Aptose Biosciences Inc.

Scrip

Hanmi/Aptose’s AML Contender Shows Early Promise

 
• By Jung Won Shin

A series of confirmed complete remissions at various doses in patients receiving Hanmi Pharmaceutical Co., Ltd. ’s in-house-developed innovative drug for acute myeloid leukemia (AML), HM43239, are mo

Scrip

Korea 2021 Roundup: License Deals, Overseas Sales Key Factors In Earnings

 
• By Jung Won Shin

As more South Korean pharma companies seek to globalize and do cross-border license deals, licensing-related income and sales from overseas subsidiaries appear to be taking on greater weight in their

Scrip

Asia Deal Watch: CJ Group Continues Spree With Majority Stake Acquisition In Batavia Biosciences

 
• By Ian Haydock, Dexter Jie Yan, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CJ CheilJedang Acquires Batavia To Expa

Scrip

Korean Biopharmas Set For Another Record Year Of Licensing Deals

 
• By Jung Won Shin

After reaching a record high value of out-licensing deals in 2020, South Korean pharma and biotech firms are seeing another year of robust partnering, with transactions poised to rise further toward y